UnannouncedVCInvestor

Decheng Capital China Life Sciences USD

Startup rounds since 2012 with a Decheng Capital China Life Sciences USD investor on the board, and the firm's own fund filings.

Raises
6
since 2012
Unannounced
0
no announcement found, of those filed since 2025
Funds
2
fund filings under the firm's name

Rounds

  1. Baylor Genetics Holdings, Inc.$50MAnnounced16 Jul 2026 · Houston, TX
  2. ImmPACT Bio USA Inc.$140MFiled before 20252 Apr 2024 · West Hills, CA
  3. SunnyBay BioTech, Inc.$2.23MFiled before 202527 Jan 2023 · Fremont, CA
  4. Levitas, Inc.$19MFiled before 202515 Jan 2021 · Menlo Park, CA
  5. Levitas, Inc.$8MFiled before 20253 Aug 2017 · San Francisco, CA
  6. GeneWeave Biosciences, Inc.$12MFiled before 20251 Mar 2012 · San Jose, CA

By year

YearRaisesUnannounced
202610
20241
20231
20211
20171
20121

Raises are checked for an announcement from 2025 on.

Funds

The firm's own fund filings, each at its latest filing.

FundFiledSizeRaised
Decheng Capital China Life Sciences USD Fund III, L.P.30 Apr 2018$450M
Decheng Capital China Life Sciences USD Fund II, L.P.17 Aug 2015$250M

Listed because a Decheng Capital China Life Sciences USD fund's filing names a director of each company. A name match is not a verified identity.